| Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632) |
|---|
| 12/07/2005 | CN1230444C Use of HIV polypeptide or peptide or polynucleotide expression construct containing HIV-cell toxicant T-lymphocyte epitope |
| 12/07/2005 | CN1230418C Selective androgen receptor modulators and methods of use thereof |
| 12/06/2005 | USRE38915 used for modulation of the activity of the insulin receptor, enhancement of glucose uptake by cells, and other effects significant in the control and management of diabetes |
| 12/06/2005 | US6973388 Using computers |
| 12/06/2005 | US6972423 Sensor |
| 12/06/2005 | US6972339 Compounds and methods for fluorescent labeling |
| 12/06/2005 | US6972328 can comprise DNA, RNA, PNA, or any combination or chimera thereof |
| 12/06/2005 | US6972326 Labeling of immobilized proteins using dipyrrometheneboron difluoride dyes |
| 12/06/2005 | US6972318 Complex of a chaperone protein with amyloid |
| 12/06/2005 | US6972198 Determining conformational state protein; obtain protein, incubate with labeled probe, detect signal from bound labeled probe, signal from probe indicates conformational adjustment |
| 12/06/2005 | US6972187 OAT5 molecules and uses therefor |
| 12/06/2005 | US6972184 Cell motility assay |
| 12/06/2005 | US6972183 generating expression libraries comprising vectors having nucleic acid sequences from microorganisms, then mixing with substrates preferential for enzymes, incubating and analyzing signals produced; microfluidics; screening for biological targets |
| 12/06/2005 | US6972182 detecting or monitoring activity of protease enzymes, using domain peptides capable of binding, forming multimeric proteins and generating detectable fluorescent signals |
| 12/06/2005 | US6972181 Differential diagnosis of cancer and other conditions based on expression of p63 |
| 12/06/2005 | US6972180 Analyzing tumor labels erbb, cancer antigens and tumor suppressorr oncogene protein 53, from saliva and evaluating against screening panels; medical diagnosis |
| 12/06/2005 | US6972179 RRP sequences and knockout mice and uses thereof |
| 12/06/2005 | US6972178 transfecting cells with genes, expressing regulatory proteins and codes for nuclear receptors, then culturing with chemicals and analyzing; bioassay; genetic engineering |
| 12/06/2005 | US6972177 Method for the detection of prion diseases |
| 12/06/2005 | US6972176 KVLQT1—a long QT syndrome gene |
| 12/06/2005 | US6972175 Inhibition of Egr-1 expression by ppar-gamma agonists and related compositions and methods |
| 12/06/2005 | US6972173 Using raman spectroscopy to determine sequence of target nucleic acid |
| 12/06/2005 | US6972172 Combinatorial complex carbohydrate library for use the detection and screening of drugs |
| 12/06/2005 | US6972170 obtaining sample of prostate carcinoma and detecting presence of p27 protein in prostate carcinoma, the absence of p27 indicating that the prostate carcinoma is aggressive |
| 12/06/2005 | US6972127 administering an effective dose of a polypeptide comprising an immunogenic fragment of A beta (SEQ ID NO:1) and an adjuvant in a regime effective to induce an immune response comprising antibodies to the A beta fragment; Alzheimer's disease |
| 12/06/2005 | US6972126 Methods for using resonance energy transfer-based assay of HIV-1 envelope glycoprotein-mediated membrane fusion, and kits for practicing same |
| 12/06/2005 | US6972122 Contrast enhancement agent for magnetic resonance imaging |
| 12/06/2005 | US6971262 System and method for rheological characterization of granular materials |
| 12/06/2005 | US6971261 Method and apparatus for determining at least one property of moving clothing in a paper machine |
| 12/06/2005 | US6971260 Overburden rock core sample containment system |
| 12/06/2005 | CA2385613C High sensitivity immunoassay method |
| 12/06/2005 | CA2362834C Modulators of beta-amyloid peptide aggregation comprising d-amino acids |
| 12/06/2005 | CA2267897C Infrared spectroscopy and imaging of libraries |
| 12/06/2005 | CA2208274C Peptide p277 analogs, and pharmaceutical compositions comprising them for treatment or diagnosis of diabetes |
| 12/06/2005 | CA2206787C 2,5-diamino-3,4-disubstituted-1,6-diphenylhexane isosteres comprising benzamide, sulfonamide and anthranilamide subunits and methods of using same |
| 12/06/2005 | CA2140683C Device for separating magnetically labelled cells |
| 12/06/2005 | CA2073282C Human herpesvirus type 6 protein p100, the corresponding dna sequences, their preparation and use |
| 12/01/2005 | WO2005114930A2 Method and apparatus for identifying proteins in mixtures |
| 12/01/2005 | WO2005114722A1 Test apparatus |
| 12/01/2005 | WO2005114700A2 Expression quantification using mass spectrometry |
| 12/01/2005 | WO2005114532A1 Synthetic gas reactor system with gas or liquid injection |
| 12/01/2005 | WO2005114243A2 Magnetic sensor array having an analog frequency-division multiplexed output |
| 12/01/2005 | WO2005114231A1 Electric conductivity water probe |
| 12/01/2005 | WO2005114225A2 Method and apparatus for determining the efficiency of a vaporizer in a decontamination system |
| 12/01/2005 | WO2005114222A1 Use of precursors of enkephalins and/or their fragments in medical diagnostics |
| 12/01/2005 | WO2005114221A2 Compositions and methods for quantification of serum glycoproteins |
| 12/01/2005 | WO2005114220A2 Compositions, kits, and methods for calibration in mass spectrometry |
| 12/01/2005 | WO2005114219A2 Assays to identify irreversibly binding inhibitors of receptor tyrosine kinases |
| 12/01/2005 | WO2005114218A2 Cross-screening system and methods for detecting a molecule having binding affinity for a target molecule |
| 12/01/2005 | WO2005114217A2 Na+ and ci> coupled transport system for endogenous opioid peptides |
| 12/01/2005 | WO2005114216A2 Stamp2 nucleic acid molecules, polypeptides, and diagnostic and therapeutic methods |
| 12/01/2005 | WO2005114215A2 Method of improving t cell receptors |
| 12/01/2005 | WO2005114214A1 Method for the detection of disease-related prion |
| 12/01/2005 | WO2005114213A2 Diagnostics and therapeutics for diseases associated with g protein-coupled receptor npy1 (npy1) |
| 12/01/2005 | WO2005114212A2 Diagnostics and therapeutics for diseases associated with g protein-coupled receptor npy4 (npy4) |
| 12/01/2005 | WO2005114211A1 Diagnostics and therapeutics for diseases associated with g protein-coupled receptor nyp5 (npy5) |
| 12/01/2005 | WO2005114210A1 Diagnostics and therapeutics for diseases associated with g protein-dependent receptor kinase 3 (grk3) |
| 12/01/2005 | WO2005114209A2 Diagnostics and therapeutics for diseases associated with g protein-dependent receptor kinase 2 (grk2) |
| 12/01/2005 | WO2005114208A1 Diagnostics and therapeutics for diseases associated with mas-related gene mrgd (mrgd) |
| 12/01/2005 | WO2005114207A2 Diagnostics and therapeutics for diseases associated with aminopeptidase n (anpep) |
| 12/01/2005 | WO2005114206A2 Diagnostics and therapeutics for diseases associated with serotonin 5-ht5a receptor (5ht5a) |
| 12/01/2005 | WO2005114205A2 Diagnostics and therapeutics for diseases associated with nuclear receptor subfamily 1, group b, member 2 (nr1b2) |
| 12/01/2005 | WO2005114204A2 Diagnostics and therapeutics for diseases associated with nuclear receptor subfamily 0, group b, member 2 (nr0b2) |
| 12/01/2005 | WO2005114203A2 Dominant b cell epitopes and methods of making and using thereof |
| 12/01/2005 | WO2005114202A2 Method for diagnosis of prostate cancer |
| 12/01/2005 | WO2005114201A1 Diagnostics and therapeutics for diseases associated with g protein-coupled receptor npy2 (npy2) |
| 12/01/2005 | WO2005114200A1 Diagnostics and therapeutics for diseases associated with g protein-coupled receptor kinase 7 (grk7) |
| 12/01/2005 | WO2005114199A1 Diagnostics and therapeutics for diseases associated with mitogen-activated protein kinase kinase kinase 5 (map3k5) |
| 12/01/2005 | WO2005114198A2 Protein phosphorylation assay |
| 12/01/2005 | WO2005114197A2 Activity-based probes for protein tyrosine phosphatases |
| 12/01/2005 | WO2005114196A1 Method of examining interstitial cystitis |
| 12/01/2005 | WO2005114195A1 Diagnostics and therapeutics for diseases associated with g protein-coupled receptor kinase 4 (grk4) |
| 12/01/2005 | WO2005114194A1 Method of quantifying the cell-binding properties of a medical device |
| 12/01/2005 | WO2005114193A1 Affinity particle and method of affinity separation |
| 12/01/2005 | WO2005114192A1 A device for binding a target entity to a bait entity and detection methods using the same |
| 12/01/2005 | WO2005114191A2 Method for a fully automated monoclonal antibody-based extended differential |
| 12/01/2005 | WO2005114190A2 Methods of identifying biomarkers |
| 12/01/2005 | WO2005114189A1 Methods of diagnosing inflammatory bowel disease |
| 12/01/2005 | WO2005114188A2 Cul4 e3 ligase mediators as regulators of p53 |
| 12/01/2005 | WO2005114187A2 Methods and compositions for diagnosing aids and other diseases and conditions involving immune system activation |
| 12/01/2005 | WO2005114186A1 Method of assaying hyaluronic acid by using hyaluronic acid-binding protein |
| 12/01/2005 | WO2005114185A2 Integrated glucose monitors and measurement of analytes via molecular oxygen modulation of dye fluorescence lifetime |
| 12/01/2005 | WO2005114184A2 Biological soil detector and method of using same |
| 12/01/2005 | WO2005114183A1 Orthodontic indicator |
| 12/01/2005 | WO2005114182A1 Histamine detection method and histamine detection kit |
| 12/01/2005 | WO2005114181A2 Assay method |
| 12/01/2005 | WO2005114180A2 Functional ghs-r antagonists |
| 12/01/2005 | WO2005114179A1 Diagnostics and therapeutics for diseases associated with nuclear receptor subfamily 0, group b, member 1 (nr0b1) |
| 12/01/2005 | WO2005114178A1 Multi-cellular test systems |
| 12/01/2005 | WO2005114177A1 Method for evaluating quality of abrasive particles, method for polishing glass and abrasive composition for polishing glass |
| 12/01/2005 | WO2005114176A2 Methods and systems for detecting hydrogen |
| 12/01/2005 | WO2005114174A2 Chemical agent detection |
| 12/01/2005 | WO2005114173A2 Hdm2-inhibitor complexes and uses thereof |
| 12/01/2005 | WO2005114164A2 Voltammetric systems for assaying biological analytes |
| 12/01/2005 | WO2005114163A1 Methods for performing hematocrit adjustment in glucose assays and devices for same |
| 12/01/2005 | WO2005114162A1 Method and device for testing gas sensors and correcting gas sensor output |
| 12/01/2005 | WO2005114161A1 Electrode calibration |
| 12/01/2005 | WO2005114160A1 Method for manufacturing a diagnostic test strip |
| 12/01/2005 | WO2005114159A1 Electrochemical cell and method of making an electrochemical cell |
| 12/01/2005 | WO2005114151A1 Measuring system |